ECM
ZSAN

Endurant Capital Management’s Zosano Pharma Corporation ZSAN Stock Holding History

Endurant Capital Management’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,182
Closed -$681K – 100
2017
Q3 		$681K Buy
1,182
+109
+10% +$79.9K 0.21% 75
2017
Q2 		$1.06M Buy
1,073
+220
+26% +$227K 0.3% 65
2017
Q1 		$1.14M Buy
+853
New +$1.03M 0.36% 63

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
HCM
Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Endurant Capital Management's ZSAN Position: Q4 2017 in Review

Endurant Capital Management sold out of Zosano Pharma Corporation (ZSAN) in Q4 2017, closing a stake of 1,182 shares — an estimated $681K sold.

Endurant Capital Management first reported a position in ZSAN in Q1 2017 and held it in 3 quarters. The position peaked at $1.14M in Q1 2017. 17 funds tracked by Wall St. Rank hold ZSAN as of Q4 2017.

  • Endurant Capital Management reported no remaining Zosano Pharma Corporation position as of Q4 2017 after selling out during the quarter.
  • Endurant Capital Management sold 1,182 Zosano Pharma Corporation shares in Q4 2017, an estimated $681K.
  • Endurant Capital Management first reported a position in Zosano Pharma Corporation in Q1 2017 and held it in 3 quarters.
  • Endurant Capital Management's Zosano Pharma Corporation position peaked at $1.14M in Q1 2017.
  • 17 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q4 2017.

Based on Endurant Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.